op 2507 has been researched along with mci 9038 in 1 studies
Studies (op 2507) | Trials (op 2507) | Recent Studies (post-2010) (op 2507) | Studies (mci 9038) | Trials (mci 9038) | Recent Studies (post-2010) (mci 9038) |
---|---|---|---|---|---|
33 | 0 | 1 | 1,087 | 83 | 349 |
Protein | Taxonomy | op 2507 (IC50) | mci 9038 (IC50) |
---|---|---|---|
Prothrombin | Homo sapiens (human) | 0.22 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kawamoto, T; Kurata, M; Ohkohchi, N; Okajima, K; Uchiba, M | 1 |
1 other study(ies) available for op 2507 and mci 9038
Article | Year |
---|---|
Antithrombin reduces reperfusion-induced hepatic metastasis of colon cancer cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antithrombins; Arginine; Cell Line, Tumor; Colonic Neoplasms; E-Selectin; Epoprostenol; Fibrin Fibrinogen Degradation Products; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Pipecolic Acids; Rats; Rats, Inbred F344; Reperfusion; RNA, Messenger; Sulfonamides; Tumor Necrosis Factor-alpha | 2006 |